Radioprotection by the soy isoflavone genistein

Herbal Radiomodulators: Applications in Medicine, Homeland Defence and Space

Volumn , Issue , 2008, Pages 163-173

  Landauer, Michael R ^a  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67651169321     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (55)

1. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N. Shibuya, M. and Fukami, Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry 262, 5592-5595.
2. Arora, R., Gupta, D., Chawla, R., Sagar, R., Sharma, A., Kumar, R., Prasad, J., Singh, S., Samanta, N. and Sharma, R.K. (2005) Radioprotection by plant products: Present status and future prospects. Phytotherapy Research 19, 1-22.
3. Bergan, R.C., Waggle, D.H., Carter, S.K., Horak, I., Slichenmyer, W. and Meyers, M. (2001) Tyrosine kinase inhibitors and signal transduction modulators, rationale and current status as chemopreventive agents for prostate cancer. Urology 57, 77-80.
4. Bump, E.A. and Malaker, K. (1998) Radioprotectors, Chemical, Biological, and Clinical Perspectives, CRC Press, Washington, D.C., p. 431.
5. Buntzel, J., Glatzel, M., Mucke, R., Micke, O. and Bruns, F. (2007) Influence of amifostine on late radiation-toxicity in head and neck cancer-a follow-up study. Anticancer Research 27, 1953-1956.
6. Cai, Q. and Wei, H. (1996) Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutrition and Cancer 25, 1-7.
7. Davis, T.A., Clarke, T.K., Mog, S.R and Landauer, M.R. (2007) Subcutaneous administration of genistein prior to lethal irradiation supports multilineage, hematopoietic progenitor cell recovery and survival. International Journal of Radiation Biology 83, 141-151.
8. Denekamp, J. (1986) Cell kinetics and radiation biology. International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine 49, 357-380.
9. Faqi, A.S, Johnson, W.D, Morrissey, R.L. and McCormick, D.L. (2004) Reproductive toxicity assessment of chronic dietary exposure to soy isoflavones in male rats. Reproductive Toxicology 18, 605-611.
10. Fischer, L., Mahoney, C., Jeffcoat, A.R., Koch, M.A., Thomas, B.F., Valentine, J.L., Stinchcombe, T., Boan, J., Crowell, J.A. and Zeisel, S.H. (2004) Clinical characteristics and pharmacokinetics of purified soy isoflavones, Multiple-dose administration to men with prostate neoplasia. Nutrition and Cancer 48, 160-170.
11. Flynn, D.F. and Goans, R.E. (2006) Nuclear terrorism, triage and medical management of radiation and combined-injury casualties. Surgical Clinics of North America 86, 601-636.
12. Food and Drug Administration (2007) Drug Preparedness and Response to Bioterrorism, Radiation Emergencies. http//www.fda.gov/cder/drugprepare/default.htm#Radiation; accessed July 29, 2007.
13. Freireich, E.J, Gehan, E.A., Rall, D.P., Schmidt, L.H. and Skipper, H.E. (1966) Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemotherapy Reports Part 1 50, 219-244.
14. Grace, M.B., Blakely, W.F. and Landauer, M.R. Genistein effects on gene expression biomarkers of radiation response. Radiation Measurements (in press).
15. Hillman, G.G., Forman, J.D., Kucuk, O., Yudelev, M., Maughan, R.L., Rubio, J., Layer, A., Tekyi-Mensah, S., Abrams, J. and Sarkar, F.H. (2001) Genistein potentiates the radiation effect on prostate carcinoma cells. Clinical Cancer Research 7, 382-390.
16. Hillman, G.G., Wang, Y., Che, M., Raffoul, J.J., Yudelev, M., Kucuk, O. and Sarkar, F.H. (2007) Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model. BMC Cancer 7, 4.
17. Hillman, G.G., Wang, Y., Kucuk, O., Che, M., Doerge, D.R., Yudelev, M., Joiner, M.C., Marples, B., Forman, J.D. and Sarkar, F.H. (2004) Genistein potentiates inhibition of tumour growth by radiation in a prostate cancer orthotopic model. Molecular Cancer Therapeutics 3, 1271-1279.
18. Hong, H., Landauer, M.R., Foriska, M.A. and Ledney, G.D. (2006) Antibacterial activity of the soy isoflavone genistein. Journal of Basic Microbiology 46, 329-335.
19. Jefremov, V., Zilmer, M., Zilmer, K., Bogdanovic, N. and Karelson, E. (2007) Antioxidative effects of plant polyphenols, from protection of G protein signaling to prevention of age-related pathologies. Annals of the New York Academy of Sciences 1095, 449-457.
20. Kruk, I, Aboul-Enein, H.Y., Michalska, T., Lichszteld, K. and Kladna, A. (2005) Scavenging of reactive oxygen species by the plant phenols genistein and oleuropein. Luminescence 20, 81-89.
21. Landauer, M.R., Davis, H.D., Dominitz, J.A. and Weiss, J.F. (1987) Dose and time relationships of the radioprotector WR-2721 on locomotor activity in mice. Pharmacology, Biochemistry and Behavior 27, 573-576.
22. Landauer, M.R. (2002) Radiation-induced performance decrement. Military Medicine 167, 128-130.
23. Landauer, M.R., Castro, C.A., Benson, K.A., Hogan, J.B. and Weiss, J.F. (2001) Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327. Journal of Applied Toxicology 21, 25-31.
24. Landauer, M.R., Davis, H.D., Kumar, K.S. and Weiss, J.F. (1992) Behavioral toxicity of selected radioprotectors. Advances in Space Research 12, 273-283.
25. Landauer, M.R., Srinivasan, S.V., Shapiro, A., Takimoto, C. and Seed, T.M. (2000) Protection against lethal irradiation by genistein. International Journal of Toxicology 19(6), 37.
26. Landauer, M.R., Srinivasan, S.V., Shapiro, A., Takimoto, C.H., Wang, P.S. and Seed, T.M. (2002) Effect of dose, time, and route of administration of genistein on radiation protection. The Toxicologist 66, 88.
27. Landauer, M.R., Srinivasan, V. and Seed, T.M. (2003b) Genistein treatment protects mice from ionizing radiation injury. Journal of Applied Toxicology 23, 379-385.
28. Landauer, M.R., Srinivasan, V., Nguyen, A.M. and Seed, T.M. (2003a) Soy phytoestrogens protect against gamma irradiation. The Toxicologist 72, 162.
29. McCue, P. and Shetty, K. (2004) Health benefits of soy isoflavonoids and strategies for enhancement, a review. Critical Reviews in Food Science and Nutrition 44, 361-367.
30. McPherson, C.W. (1963) Reduction of Pseudomonas aeruginosa and coliform bacteria in mouse drinking water following treatment with hydrochloric acid and chlorine. Laboratory Animal Care 13, 737-744.
31. Montoro, P., Braca, A., Pizza, C. and De Tommasi, N. (2005) Structure-antioxidant activity relationship of flavonoids isolated from different plant species. Food Chemistry 92, 349-355.
32. Morris, S.M., Akerman, G.S., Warbritton, A.R., Patton, R.E., Doerge, D.R., Ding, X. and Chen, J.J. (2003) Effect of dietary genistein on cell replication indices in C57BL6 mice. Cancer Letters 195, 139-145.
33. Neta, R. (1998) Modulation of the radiation response by cytokines. In: Bump, E.A and Malaker, K. (eds) Radioprotectors, Chemical, Biological, and Clinical Perspectives. CRC Press, New York, USA, pp. 237-252.
34. Newman, D.J. and Cragg, G.M. (2007) Natural products as sources of new drugs over the last 25 years. Journal of Natural Products 70, 461-477.
35. Papazisis, K.T., Zambouli, D., Kimoundri, O.T., Papadakis, E.S., Vala, V., Geromichalos, G.D., Voyatzi, S., Markala, D., Destouni, E., Boutis, L. and Kortsaris, A.H. (2000) Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with gamma-irradiation. Cancer Letters 160, 107-113.
36. Patchen, M. (1998) Immunomodulators and cytokines, their use in the mitigation of radiation-induced hemopoietic injury. In: Bump, E.A. and Malaker, K. (eds) Radioprotectors, Chemical, Biological, and Clinical Perspectives. CRC Press, New York, pp. 213-236.
37. Pellmar, T.C. (2006) Radiological/nuclear preparedness. Military Medical Technology (Online Edition) http//www.military-medical-technology.com/article.cfm?DocID=1430 10.
38. Pietta, P.G. (2000) Flavonoids as antioxidants. Journal of Natural Products 63, 1035-1042.
39. Rades, D., Fehlauer, F., Bajrovic, A., Mahlmann, B., Richter, E. and Alberti, W. (2004) Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiotherapy and Oncology 70, 261-264.
40. Raffoul, J.J., Banerjee, S., Che, M., Knoll, Z.E., Doerge, D.R., Abrams, J., Kucuk, O., Sarkar, F.H. and Hillman, G.G. (2007) Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model. International Journal of Cancer 120, 2491-2498.
41. Shimizu, S. (2004) Routes of administration. In: Hedrich, H.J. and Bullock, G. (eds) The Laboratory Mouse, Elsevier Academic Press, San Diego, CA, USA, pp. 527-542.
42. Singh, V.K. and Yadav, V.S. (2005) Role of cytokines and growth factors in radioprotection. Experimental and Molecular Pathology 78, 156-169.
43. Stone, H.B., Moulder, J.E., Coleman, C.N., Ang, K.K., Anscher, M.S., Barcellos-Hoff, M.H., Dynan, W.S., Fike, J.R., Grdina, D.J., Greenberger, J.S., Hauer-Jensen, M., Hill, R.P., Kolesnick, R.N., Macvittie, T.J., Marks, C., McBride, W.H., Metting, N., Pellmar, T., Purucker, M., Robbins, M.E., Schiestl, R.H., Seed, T.M., Tomaszewski, J.E., Travis, E.L., Wallner, P.E., Wolpert, M. and Zaharevitz, D. (2004) Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiation Research 162, 711-728.
44. Storer, J., Fry, R. and Ullrich, R. (1982) Somatic effects of radiation. In: Foster, H., Small, J. and Fox, J. (eds) The Mouse in Biomedical Research, Volume IV Experimental Biology and Oncology, Academic Press, New York, USA, pp. 133-146.
45. Sugano, M. (2006) Soy in Health and Disease Prevention, Taylor and Francis, New York, USA.
46. Takimoto, C.H., Glover, K., Huang, X., Hayes, S.A., Gallot, L., Quinn, M., Jovanovic, B.D., Shapiro, A., Hernandez, L., Goetz, A., Llorens, V., Lieberman, R., Crowell, J.A., Poisson, B.A. and Bergan, R.C. (2003) Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer Epidemiology, Biomarkers and Prevention 12, 1213-1221.
47. Uma Devi, P., Ganasoundari, A., Rao, B.S. and Srinivasan, K.K. (1999) In vivo radioprotection by Ocimum flavonoids, survival of mice. Radiation Research 151, 74-78.
48. Valachovicova, T., Slivova, V. and Sliva, D. (2004) Cellular and physiological effects of soy flavonoids. Mini Reviews in Medicinal Chemistry 4, 881-887.
49. Verdrengh, M., Jonsson, I.M., Holmdahl, R. and Tarkowski, A. (2003) Genistein as an antiinflammatory agent. Inflammation Research 52, 341-346.
50. Wang, Y., Raffoul, J.J., Che, M., Doerge, D.R., Joiner, M.C., Kucuk, O., Sarkar, F.H. and Hillman, G.G. (2006) Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumour model. Radiation Research 166, 73-80.
51. Waselenko, J.K., MacVittie, T.J., Blakely, W.F., Pesik, N., Wiley, A.L., Dickerson, W.E., Tsu, H., Confer, D.L., Coleman, C.N., Seed, T., Lowry, P., Armitage, J.O. and Dainiak, N. (2004) Medical management of the acute radiation syndrome, recommendations of the Strategic National Stockpile Radiation Working Group. Annals of Internal Medicine 140, 1037-1051.
52. Winkel-Shirley, B. (2002) Biosynthesis of flavonoids and effects of stress. Current Opinion in Plant Biology 5, 218-223.
53. Yashar, C.M., Spanos, W.J., Taylor, D.D. and Gercel-Taylor, C. (2005) Potentiation of the radiation effect with genistein in cervical cancer cells. Gynecologic Oncology 99, 199-205.
54. Zhang, B., Liu, J.Y., Pan, J.S., Han, S.P., Yin, X.X., Wang, B. and Hu, G. (2006) Combined treatment of ionizing radiation with genistein on cervical cancer HeLa cells. Journal of Pharmacological Sciences 102, 129-135.
55. Zhou, Y. and Mi, M.T. (2005) Genistein stimulates hematopoiesis and increases survival in irradiated mice. Journal of Radiation Research 46, 425-433.